Browse Category

NYSE:CRM News 29 December 2025 - 9 January 2026

Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce shares slipped 0.2% to $260.01 after unveiling its Spring ’26 product release, featuring new AI and automation tools, set to roll out from Feb. 23. U.S. payrolls rose by 50,000 in December, below forecasts, while unemployment fell to 4.4%. The S&P 500 hit a record intraday high after the jobs report. Fed funds futures priced in a 4.8% chance of a rate cut at the next Fed meeting.
Salesforce stock rises as tech steadies after soft jobs data; CRM investors eye Friday payrolls

Salesforce stock rises as tech steadies after soft jobs data; CRM investors eye Friday payrolls

Salesforce shares rose 1.6% to $267.13 in afternoon trading Wednesday, with about 3.7 million shares exchanged. The move followed volatile trading as investors weighed weaker-than-expected U.S. private payrolls data and awaited Friday’s jobs report. Salesforce is set to pay a $0.416 per share dividend on January 8. Traders are watching the pace of the company’s AI monetization into 2026.
7 January 2026
Salesforce stock rises as RBC lifts target to $290, AI bets back in focus for CRM shares

Salesforce stock rises as RBC lifts target to $290, AI bets back in focus for CRM shares

New York, January 6, 2026, 14:42 EST — Regular session Salesforce (CRM) shares climbed 2.6% to $262.82 in afternoon trading on Tuesday, tracking a broader bid for large-cap software names as investors leaned back into AI-linked trades. The move matters because sentiment in enterprise software has turned on a narrow question: which vendors can turn artificial intelligence into billable products without stalling core subscription growth. Salesforce sits near the center of that debate as it pushes AI “agent” tools aimed at automating customer-facing work. Rate bets are also back in play. Growth stocks tend to move with expectations for Federal
Salesforce stock rises as RBC lifts target; $250 level and jobs report loom

Salesforce stock rises as RBC lifts target; $250 level and jobs report loom

New York, Jan 5, 2026, 21:06 EST — Market closed Salesforce shares rose 1.1% to $256.26 on Monday, snapping a three-session slide. The customer-relationship-management software maker is still about 30% below its 52-week high and traded lighter-than-average volume, according to MarketWatch data. marketwatch.com The move comes as Wall Street tries to pin down which large-cap software names can turn “AI agents” — software that can take actions on a user’s behalf — into billable growth. RBC Capital Markets analyst Rishi Jaluria raised his price target on Salesforce to $290 from $250 and kept a Sector Perform rating, roughly a hold
Salesforce stock rises as RBC lifts price target, AI demand back in focus

Salesforce stock rises as RBC lifts price target, AI demand back in focus

New York, Jan 5, 2026, 11:23 ET — Regular session Salesforce shares rose about 1.4% to $257.07 on Monday, tracking a firmer tone in U.S. equities after RBC Capital Markets raised its price target on the enterprise software maker. The call matters because investors are starting the year still debating whether “enterprise AI” spending is translating into recurring revenue, not just pilot projects. Salesforce has positioned its newer AI agent products as a growth driver, and analyst target changes can shape near-term positioning in a stock that is widely held and sits in the Dow. It also lands as traders
Cloud computing stocks slide into 2026 as yields rise — what CLOU ETF investors watch next

Cloud computing stocks slide into 2026 as yields rise — what CLOU ETF investors watch next

NEW YORK, January 4, 2026, 13:43 ET — Market closed The Global X Cloud Computing ETF fell 2.34% on Friday to $22.09, ending the first U.S. trading session of 2026 on the back foot as investors trimmed rate-sensitive cloud software exposure. Global X ETFs The timing matters because cloud stocks have become a crowded way to express bets on corporate digital spending and AI-linked demand, but they tend to wobble when bond yields rise. On Friday, U.S. stocks finished mixed with the Nasdaq edging lower as megacap tech weighed, while Treasury yields climbed. Reuters Policy expectations are also moving. Philadelphia
Salesforce stock slides 4% to start 2026 as CRM traders eye jobs report, earnings date

Salesforce stock slides 4% to start 2026 as CRM traders eye jobs report, earnings date

NEW YORK, Jan 4, 2026, 10:37 ET — Market closed Salesforce Inc shares ended the first trading day of 2026 down 4.26%, closing at $253.62 on Friday, a sharp pullback in a Dow component that investors often treat as a read on corporate software spending. Investing The move matters now because high-multiple software stocks tend to react quickly when interest-rate expectations change. Higher bond yields can pressure valuations by lifting the discount rate investors apply to future earnings. Reuters A packed week of U.S. data after a disrupted release calendar is also back in focus. The Labor Department’s Employment Situation
Why Pegasystems (PEGA) stock sank Friday — and what Wall Street watches next

Why Pegasystems (PEGA) stock sank Friday — and what Wall Street watches next

NEW YORK, Jan 3, 2026, 20:59 ET — Market closed • Pegasystems shares fell 6.1% on Friday, underperforming a weak session for software stocks• The software sector lagged even as chipmakers lifted the Dow and S&P 500 in the first U.S. session of 2026• Traders are watching the Jan. 9 U.S. jobs report and whether PEGA holds Friday’s intraday low before Monday’s open Pegasystems Inc shares slid 6.1% on Friday to close at $56.06, after dropping as low as $55.33 in the first U.S. trading session of 2026. Yahoo Finance The move matters because it arrived alongside an early-year rotation
Salesforce stock slides 4% as 2026 opens — here’s what’s driving CRM and what investors watch next

Salesforce stock slides 4% as 2026 opens — here’s what’s driving CRM and what investors watch next

NEW YORK, Jan 3, 2026, 10:35 ET — Market closed Salesforce, Inc. shares closed down 4.26% on Friday at $253.62, their first regular-session finish of 2026, after trading between $252.48 and $265.38. The stock is about 31% below its 52-week high of $367.09. Investing The move matters now because Salesforce is a bellwether for enterprise software demand, and investors are starting the year debating how quickly corporate buyers will translate “AI” features into incremental spending. Salesforce has been treated as an AI-linked large-cap software name, leaving it sensitive to shifts in risk appetite and valuations. U.S. stocks started 2026 on
3 January 2026
Salesforce stock slides 4% to start 2026 — CRM investors brace for jobs data and earnings

Salesforce stock slides 4% to start 2026 — CRM investors brace for jobs data and earnings

NEW YORK, January 3, 2026, 05:51 ET — Market closed Salesforce (CRM) shares closed down 4.26% at $253.62 on Friday, marking a weak start to 2026 for the cloud software bellwether. ServiceNow and DocuSign also fell, underscoring broader pressure across enterprise software. Stooq The drop came as the Dow and S&P 500 ended higher, helped by a rally in chipmakers, while some big technology names retreated, Reuters reported. “Investors might be a little bit more conscious about some of the valuations that they’re paying for some of the AI plays,” said Joe Mazzola, head of trading and derivatives strategist at
Salesforce stock (CRM) drops 4% as 2026 opens; investors eye jobs report and next earnings

Salesforce stock (CRM) drops 4% as 2026 opens; investors eye jobs report and next earnings

NEW YORK, January 2, 2026, 17:50 ET — After-hours Salesforce, Inc. shares were down 4.3% at $253.62 in after-hours trade on Friday, after moving between $252.49 and $267.00 during the session, according to market data. The slide put pressure on a large-cap software name that investors often use as a read on corporate IT budgets and the pace of enterprise adoption of new tools, including generative AI. It also mattered for the Dow, which is price-weighted — meaning higher-priced stocks have a bigger impact on the index than lower-priced ones. MarketWatch data showed Salesforce and Travelers were the biggest drags
Dow Jones today: Caterpillar, Boeing lift blue chips as investors eye jobs report and Fed path

Dow Jones today: Caterpillar, Boeing lift blue chips as investors eye jobs report and Fed path

NEW YORK, Jan 2, 2026, 13:36 ET — Regular session The Dow Jones Industrial Average was up 78.93 points, or 0.16%, at 48,142.22 in early afternoon trading on Friday, after swinging between 47,853.04 and 48,275.63. Investing The muted rise matters because it is the first full trading session of 2026, and Wall Street is trying to steady after a late-December slide. Investors are also recalibrating expectations for interest rates after the market’s year-end “Santa Claus rally” — a seasonal tendency for stocks to rise into early January — failed to gain traction. Traders are now looking to next week’s U.S.
Salesforce stock today: Benioff’s MrBeast Super Bowl pitch keeps CRM in focus as markets shut for New Year’s

Salesforce stock today: Benioff’s MrBeast Super Bowl pitch keeps CRM in focus as markets shut for New Year’s

NEW YORK, January 1, 2026, 18:36 ET — Market closed. Salesforce, Inc. shares edged lower in the last trading session before the New Year’s Day holiday, as Chief Executive Marc Benioff drew attention online by inviting YouTube star MrBeast to create the company’s 2026 Super Bowl commercial. “Very seriously, Jimmy you should really do our Salesforce Super Bowl commercial for 2026!” Benioff wrote. The stock last closed down about 0.4% at $264.91. San Francisco Chronicle+1 The unusual consumer-facing pitch lands as investors head into 2026 focused on whether Salesforce’s Agentforce push can translate into steadier demand and clearer monetization. Agentforce
2 January 2026
Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

NEW YORK, December 31, 2025, 19:03 ET — After-hours Salesforce, Inc. shares ended down 0.4% on Wednesday and hovered near $264.91 in after-hours trading, as the cloud software maker closed out 2025’s final session on a subdued note. The stock traded between $264.44 and $266.12 during the session. The late drift underscored how thin year-end liquidity can magnify moves in large-cap technology names, even without fresh company news. For Salesforce, the timing matters because investors are resetting exposure ahead of 2026, when spending on enterprise software and new AI features is expected to be under sharper scrutiny. A Yahoo Finance
Salesforce stock today: CRM slips in late-year session as software shares soften

Salesforce stock today: CRM slips in late-year session as software shares soften

NEW YORK, December 31, 2025, 15:39 ET — Regular session Salesforce Inc shares edged lower on Wednesday, down about 0.3% at $265.06 in late-afternoon trading. The stock traded between $264.44 and $266.12, with roughly 1.7 million shares changing hands. The move tracked a softer tape for software names into the final session of 2025. The iShares Expanded Tech-Software Sector ETF (IGV) was down about 1.1%, while the Invesco QQQ Trust (QQQ), a proxy for the Nasdaq-100, fell about 0.7%. That matters now because cloud software valuations tend to swing with expectations for U.S. interest rates, and year-end trading can amplify
31 December 2025
Salesforce stock (CRM) slips after-hours as year-end tech trade cools and Fed minutes bite

Salesforce stock (CRM) slips after-hours as year-end tech trade cools and Fed minutes bite

NEW YORK, December 30, 2025, 18:23 ET — After-hours Salesforce (CRM) shares slipped 0.1% in after-hours trading on Tuesday to $265.92. The stock opened at $266.66 and traded between $265.38 and $268.21 during the regular session, with volume around 3.3 million shares. The late-day drift matters because year-end trading is thin, and small orders can move large-cap software names more than usual. With 2026 positioning under way, investors are quick to trim risk when the tape softens. Salesforce sits at the intersection of two themes that have dominated markets into the close of 2025: interest-rate expectations and a race to
Salesforce stock today: CRM ticks up as Fed minutes loom in thin year-end trade

Salesforce stock today: CRM ticks up as Fed minutes loom in thin year-end trade

NEW YORK, December 30, 2025, 12:06 ET — Regular session Salesforce (NYSE:CRM) shares inched higher on Tuesday as investors positioned ahead of U.S. Federal Reserve minutes due later in the day. The stock was up about 0.2% at $266.84 in midday trading. Federal Reserve The Fed release matters now because interest-rate expectations can quickly reset valuations for growth stocks, including subscription-based software companies. Investors often use the minutes to gauge whether policymakers are leaning toward more rate cuts or a longer pause. Reuters Trading was thin heading into year-end, with U.S. markets set to close on Thursday for New Year’s
30 December 2025
Salesforce stock today: CRM barely budges as year-end tech trade cools — what investors watch next

Salesforce stock today: CRM barely budges as year-end tech trade cools — what investors watch next

NEW YORK, December 29, 2025, 18:19 ET — After-hours Salesforce, Inc. shares edged higher on Monday and were flat in after-hours trading, holding up better than the broader tech sector as Wall Street entered the final three sessions of 2025. The stock ended up 0.06% at $266.23 and was little changed after 4 p.m. ET, when shares continue to trade outside regular market hours. StockAnalysis The muted move matters now because investors are testing how much of 2025’s technology-led rally can carry into January, with year-end positioning keeping trading choppy. Salesforce is also a bellwether for enterprise software budgets, and
30 December 2025
Salesforce stock holds up as year-end tech pullback hits AI bellwethers

Salesforce stock holds up as year-end tech pullback hits AI bellwethers

NEW YORK, December 29, 2025, 12:47 ET — Regular session Salesforce shares were little changed in midday trading on Monday, holding near $266 as technology and AI-linked stocks pulled back in the final week of 2025. The muted move in the enterprise-software bellwether comes as investors lock in gains and rebalance portfolios during a holiday-shortened stretch when thin liquidity can amplify market swings. Reuters Traders are watching Federal Reserve meeting minutes and a weekly reading of U.S. jobless claims for clues on 2026 rate expectations, with U.S. markets shut on Thursday for New Year’s Day. Reuters At 12:47 p.m. ET,

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop